This key provides the non-specialist with reference material to help recognise an invasive mosquito species and gives details on the morphology to help with verification.
This guidance aims to provide EU/EEA countries with an evidence-based framework to help develop, implement, monitor and evaluate their own national HBV, HCV and HIV testing guidelines and programmes.
While the number of mosquito-borne diseases in Europe is currently low, there is an increasing trend in their global incidence and geographical distribution.
This handbook uses maps produced through the non-linear discriminate analysis methodology and interprets them to show the potential for Ae. albopictus to spread further in Europe.
ECDC has produced these guidelines which aim to support the implementation of tailored surveillance for invasive mosquito species of public health relevance.
This evidence-based guidance is designed to inform the development, monitoring and evaluation of national strategies and programmes in countries in Europe in order to reduce and prevent infections among people who inject drugs.
The content of this joint guidance was developed by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the support of a technical advisory group composed of policy makers, service providers, civil society representatives and preventative health experts from throughout the EU/EEA.